Publications du Dr Khaled Effendi

1. Spinal navigation for posterior instrumentation of C1-2 instability using a mobile intraoperative CT scanner. Czabanka M, Haemmerli J, Hecht N, Foehre B, Arden K, Liebig T, Woitzik J, Vajkoczy P. J Neurosurg Spine. 2017 Sep;27(3):268-275. doi: 10.3171/2017.1.SPINE16859. Epub 2017 Jun 9.

2. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Sakamoto M, Tsujikawa H, Effendi K, Ojima H, Harada K, Zen Y, Kondo F, Nakano M, Kage M, Sumida Y, Hashimoto E, Yamada G, Okanoue T, Koike K. Pathol Int. 2017 Jan;67(1):1-7. doi:10.1111/pin.12485. Epub 2016 Dec 20. Review. No abstract available.

3. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma. Masugi Y, Tanese K, Emoto K, Yamazaki K, Effendi K, Funakoshi T, Mori M, Sakamoto M. Pathol Int. 2015 Dec;65(12):627-34. doi: 10.1111/pin.12351. Epub 2015 Sep 16.

4. Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma. Effendi K, Yamazaki K, Fukuma M, Sakamoto M. Liver Cancer. 2014 Oct;3(3-4):451-7. doi: 10.1159/000343873. Review.